Bloodreserved technology during surgical treatment of mitral valve dedeases

  • B. N. Gumenyuk National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • V. V. Popov National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • O. B. Gumenyuk National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • S. P. Spisarenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
  • V. V. Lazorishinetz National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine (Kyiv)
Keywords: cardiopulmonary bypass, method without using donor blood, correction of mitral valve

Abstract

Usage of donor blood during operations of mitral valve replacement with usage of donor blood components is associated with different possible complications, which stimulates to search measures for not using ше. In department of acquired heart diseases of NICVS AMS Ukraine from 01.01.2000. till 01.01.2017 were performed 717 isolated mitral valve replacements, in treatment of whom during hospital period components of donor blood were not used. Methodics of anesteological and perfusiological treatment in mitral valve replacemnt with cardiopulmonary bypass was described, and alsopeculiarities in intensive care unit. Hospital mortality was 1,4%, duration of stay in intensive care unit 54,2±4,7 hours, duration of stay in surgical department – 7,9±0,7 days. At discharge this group of patients had moderate anemia. Usage of developed method-ics in clinical practice allowed to get good clinical effect, avoiding posttransfusion complications on hospital stage.

References

1. Кровозберігаюча технологія при хірургічному лікуванні мітральних вад серця в умовах штучного кровообігу / Лазоришинець В. В., Попов В. В., Гуменюк Б. Н. та ін. // Журнал Національної академії медичних наук України. – 2016. – Том 22, № 1.– С. 80–86.

2. Кровосберегающая технология в хирургии митральных пороков сердца / Лазоришинец В. В., Попов В. В., Гуменюк Б. Н. и др. // Кардиология в Беларуси. – 2016. – Т. 8, № 3. – С. 21–25.

3. Intraoperative blood requirements and allogeneic blood transfusion in cardioanesthesia. Data analysis of 7729 pa-tients in 12 cardiac surgical clinics / W. Dietrich, J. U. Lu-th, J. Kormann [et al.] // Anaesthesist. – 1999. – Vol. 48, № 12. – P. 876–883.

4. Handbook of Transfusion Medicine / Editor D B L McClel-land. – London : TSO, 2007. – Vol. 31, № 15. – P. 26–27.

5. Autologous blood transfusion in elective cardiac valve op-erations // Lewis C. E. [et al.] // J. Card. Surg. – 2005. – Vol. 20. – P. 513–518.

6. Nydegger U. Transfusion dependency in cardiac surgery update 2006 / U. Nydegger // Swiss Med. Wkly. – 2006. – Vol. 136. – P. 781–788.

7. Perioperative blood transfusion and blood conservation in cardiac surgery / Spiess B. D. [et al.] // Annals of Thoracic Surgery. – 2007. – Vol. 83. – P. 27–86.

8. Transfusion triggers for guiding rbc transfusion for cardio-vascular surgery: a systematic review and meta-analysis / Curley G. F., Shehata N., Mazer C. D. [et al.] // Crit care Med. – 2014. – Vol. 42. – P. 2611–24.

9. Variation in transfusion rates within a single institution: exploring of blood product transfusion in patients undergoing cardiac surgery / Cote C., Macleod J. B., Yip A. M. et al. // J Thorac Cardiovasc Surg. – 2015. – Vol. 149. – P. 297–302.

10. Effect of hospital culture on blood transfusion in cardiac procedures / Jin R., Zelinka E. S., McDonald J. et al. // Ann Thorac Surg. – 2013. – Vol. 95. – P. 1269–74.
Published
2018-05-14
How to Cite
1.
Gumenyuk BN, Popov VV, Gumenyuk OB, Spisarenko SP, Lazorishinetz VV. Bloodreserved technology during surgical treatment of mitral valve dedeases. ujcvs [Internet]. 2018May14 [cited 2024Dec.22];(2 (31):46-1. Available from: http://cvs.org.ua/index.php/ujcvs/article/view/69
Section
ACQUIRED HEART DISEASES